CLASS II Device recall · Reported 3 Aug 2022 · FDA Enforcement Report

Centricity PACS recalled by GE Healthcare

GE Healthcare is recalling Centricity PACS, distributed nationwide in the US. The recall was initiated on 14 Jun 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel: 5831882-012, Software Version 7.0 SP0.0.4.7 GTIN: 00840682145572
Quantity recalled47 installations

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1466-2022
FDA event ID
90525
Recalling firm
GE Healthcare, Waukesha, WI
Classification
Class II
Status
Terminated
Recall initiated
14 Jun 2022
FDA classified
25 Jul 2022
Reported
3 Aug 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

14 Jun 2022Recall initiated by company
25 Jul 2022Classified by FDA+41 days
3 Aug 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Event Notification Manager (ENM) functionality for certain products does not process notifications for study modifications performed on post verified exams.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Centricity PACS Software Version 7.0 SP0.0.4.7

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of CO, NV, OH, PA, WA and the countries of Brazil, Canada, China, France, Germany, Israel, Italy, Japan, Oman, Spain, Switzerland, and United Kingdom.

Nationwide ColoradoNevadaOhioPennsylvaniaWashington

Questions about this recall

Why was it recalled?

The Event Notification Manager (ENM) functionality for certain products does not process notifications for study modifications performed on post verified exams.

Which lots are affected?

Model: 5831882-012, Software Version 7.0 SP0.0.4.7 GTIN: 00840682145572

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of CO, NV, OH, PA, WA and the countries of Brazil, Canada, China, France, Germany, Israel, Italy, Japan, Oman, Spain, Switzerland, and United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from GE Healthcare

All 518

Other Medical Software recalls

All 908